Myeloid cell‐derived tumor necrosis factor‐alpha promotes sarcopenia and regulates muscle cell fusion with aging muscle fibers

por Wang, Ying, Welc, Steven S., Wehling‐Henricks, Michelle, Tidball, James G.
Publicado 2018

Myeloid cell-mediated targeting of LIF to dystrophic muscle causes transient increases in muscle fiber lesions by disrupting the recruitment and dispersion of macrophages in muscle

por Flores, Ivan, Welc, Steven S, Wehling-Henricks, Michelle, Tidball, James G
Publicado 2021

The Impact of Hyperthermia on Receptor-Mediated Interleukin-6 Regulation in Mouse Skeletal Muscle

por Welc, Steven S., Morse, Deborah A., Mattingly, Alex J., Laitano, Orlando, King, Michelle A., Clanton, Thomas L.
Publicado 2016

Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy

por Welc, Steven S., Flores, Ivan, Wehling-Henricks, Michelle, Ramos, Julian, Wang, Ying, Bertoni, Carmen, Tidball, James G.
Publicado 2019

Myeloid cell‐specific mutation of Spi1 selectively reduces M2‐biased macrophage numbers in skeletal muscle, reduces age‐related muscle fibrosis and prevents sarcopenia

por Wang, Ying, Welc, Steven S., Wehling‐Henricks, Michelle, Kong, Ying, Thomas, Connor, Montecino‐Rodriguez, Enca, Dorshkind, Kenneth, Tidball, James G.
Publicado 2022

Muscle-Specific Ablation of Glucose Transporter 1 (GLUT1) Does Not Impair Basal or Overload-Stimulated Skeletal Muscle Glucose Uptake

por McMillin, Shawna L., Evans, Parker L., Taylor, William M., Weyrauch, Luke A., Sermersheim, Tyler J., Welc, Steven S., Heitmeier, Monique R., Hresko, Richard C., Hruz, Paul W., Koumanov, Francoise, Holman, Geoffrey D., Abel, E. Dale, Witczak, Carol A.
Publicado 2022